drugset / Trial / NCT01383694

Effect Of Piperine In Patients With Oropharyngeal Dysphagia

NCT01383694

Phase 1/2 Completed 40 enrolled Hospital de Mataró
RandomizedParallel-groupDouble-blindTreatment

Summary

Piperine acts on the oropharyngeal TRPV1, increasing sensory input and the release of substance P. These actions may accelerate the oropharyngeal swallow response, improving the swallowing of dysphagic patients.

Timeline

Start
2011-06
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Piperine Other / unclassified 0.15 mmol
Subject Piperine Other / unclassified 1 mmol

Indications

No indication recorded.